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Abstract
Background: Falls are common among elderly people, and the risk increase with age. Falls are associated with
both health and social consequences for the patient, and major societal costs. Identification of risk factors should
be investigated to prevent falls. Previous studies have shown anemia to be associated with increased risk of falling,
but the results are inconsistent. The aim of this study was to investigate the association between anemia and
self-reported falls among community-living elderly people. The study is a replication of the study by Thaler-Kall and
colleagues from 2014, who studied the association between anemia and self-reported falls among 967 women and
men 65 years and older in the KORA-Age study from 2009.
Methods: We included 2441 participants (54% women) 65 years and older from the population-based Tromsø 5 Study
2001-2002. Logistic regression models were used to investigate the association between anemia (hemoglobin <12 g/
dL in women and <13 g/dL in men) or hemoglobin level and self-reported falls last year, adjusted for sex, age, medication
use and disability. Further, associations between combinations of anemia and frailty or disability, and falls, were investigated.
Results: No statistical significant associations were found between anemia and falls (OR 95% CI: 0.83, 0.50-1.37)
or hemoglobin level and falls (OR, 95% CI: 0.94, 0.81-1.09), or with combinations of anemia and frailty or disability, and
falls (OR, 95%: CI: 0.94, 0.40-2.22 and 0.78, 0.34-1.81, respectively).
Conclusions: In this replication analysis, in accordance with the results from the original study, no statistically significant
association between anemia or hemoglobin and falls was found among community-living women and men aged
65 years or older.
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Background
Falls are one of the major public health problems among
elderly people. Among community-living elderly aged 65
and older, 30% experience a fall at least once a year [1, 2].
Falls can result in physical injuries and are associated with
higher risk of mortality [3, 4]. Falls can also result in fear
for future falls [5], leading to consequences like social iso-
lation. Falls are also associated with high societal costs [6].
Previous studies have found various risk factors for falls in
elderly people, including use of medications like sedatives
[2, 7, 8], analgesics and antiepileptics [1], urinary incontin-
ence [1], abnormalities in balance and gait, as well as other
disabilities [1, 2, 8]. Due to the serious consequences, the
identification of modifiable risk factors for falls of elderly
people is important.
Anemia, defined by the World Health Organisation
(WHO) criteria [9] as a hemoglobin level below 12 g/dL
in women and below 13 g/dL in men [9], is common in
old age. Anemia has a prevalence of 24% among elderly
worldwide [9] and has symptoms including low energy,
fatigue, dizziness, and general weakness. In the third Na-
tional Health and Nutrition Examination Survey
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(NHANES III) study, the prevalence of anemia was 11%
in elderly aged 65 years and older [10]. Similar preva-
lence has been found in the Longitudinal Ageing Study
Amsterdam [11] and in the InChianti Study [12].
Anemia prevalence increases rapidly after the age of 50,
approaching a rate of over 20% in elderly aged 85 years
or older [10], and has been found to be up to 65%
among nursing home residents [8]. In one third of the
elderly in the NHANES III, anemia could not be
explained by malnutrition or underlying disease [10].
Late life anemia is associated with subsequent physical
decline [3], like impaired physical performance not ex-
plained by disease [13], increased disability, and muscle
weakness [12]. Anemia has found to be an independent
risk factor for falls among hospitalized older adults [14],
nursing home residents [8, 15], and among community-
living elderly when injurious falls [16] or recurrent falls
[11] are the outcome. However, there is a need for fur-
ther studies of the association between anemia and all
falls among community-living elderly people.
The association between anemia and falls has been ex-
amined in 967 community-living women and men aged
65 and older in the KORA (Cooperative Health Research
in the Region of Augsburg)-Age study in 2009, published
by Thaler-Kall et al. [17]. KORA-Age is a follow-up
study of the four MONICA (Multinational MONItoring
of trends and determinants in CArdiovascular disease)/
KORA Augsburg Surveys [18] from the region of Augs-
burg in Germany. An association between anemia and
falls was not found in this general population of elderly
women and men [17]. These results differ from other
studies [11, 16]. In 394 participants from the Longitu-
dinal Ageing Study Amsterdam [11] using fall calendars
in a follow-up time of 3 years, anemia was a significant
predictor of the outcome recurrent falls. In a study of
47,530 managed care Medicare enrolled patients (709
cases) in the US, anemia was associated with the
outcome injurious falls. Differences in methodology may
give different results. It is therefore of interest to
perform a replication study using the same analysis as in
KORA-Age with data from the population based
Tromsø Study, which has a design similar to the KORA-
Age Study. The objective of the present study is to in-
vestigate the relationship between anemia and falls
among community-living elderly people, by performing
the same analysis in a sample from the Tromsø Study as
previously performed in KORA-Age.
Methods
The Tromsø Study
The Tromsø Study (9) is an ongoing population-based
study in the municipality of Tromsø, North Norway. The
study includes seven surveys (Tromsø 1: 1974, Tromsø 2:
1979-80, Tromsø 3: 1986-7, Tromsø 4: 1994-95, Tromsø
5: 2001-02, Tromsø 6: 2007-08 and Tromsø 7: 2015-16) to
which total birth cohorts and representative samples were
invited (participation rates 65-79%). A total of 45,473
women and men have participated in one or more sur-
veys. Data collection includes questionnaires and inter-
views, biological sampling, and clinical examinations. The
Tromsø Study has been approved by The Regional Com-
mittee of Medical and Health Research Ethics (REC
North) and the Norwegian Data Protection Authority.
The participants have given written informed consent.
Sample
In 2001-02 a total of 8130 women and men partici-
pated in the fifth Tromsø Study (Tromsø 5). Of these,
1885 women and 1594 men were 65 years or older
(participation rate 85% and 88%, respectively). The
total sample was invited to a first visit including
questionnaires and interviews, physical examinations
and biological sampling. A subsample attended a
second visit including new biological sampling and
extended clinical examinations. Eligible for the
present analysis were participants aged 65 years and
older who 1) answered the fall-question in the inter-
view at the first visit and 2) had a valid hemoglobin
measurement from the second visit. We excluded par-
ticipants with withdrawn consent (n = 66), younger
than 65 years (n = 4619), and participants who had
not answered the fall-question at the interview at the
first visit and/or were without valid hemoglobin
measurement from the second visit (n = 1004).
Altogether, we included 2441 participants.
Hemoglobin and fall measurements
Blood samples were collected by standard methods by
trained personnel, with the participant sitting. A brief
venous stasis applied to the upper arm was released
before venipuncture. Hemoglobin was analyzed by an
automated blood cell counter (Coulter Counter, Beck-
man Coulter, Inc., Brea, California) at the Department
of Laboratory Medicine, University Hospital of North
Norway, Tromsø. As in the KORA-Age study, the
hemoglobin level was considered both as a continu-
ous variable and as a dichotomous variable (anemic
or non-anemic defined via the WHO criteria [9] as
hemoglobin level < 12 g/dL and <13 g/dL, for women
and men, respectively). Information on falls were col-
lected with a standard single interview question (“Did
you ever fall last year?”), by trained personnel. In
KORA-Age the fall question was almost identical
(«Did you fall in the previous year?”), originally
derived from the NHANES Study 2003-2004 [19]
(“During the past 12 months, have you had difficulty
with falling?”).
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Covariates
To match the analyses performed in the KORA-Age
Study, we included the following variables as covariates:
sex, age, hypertension (blood pressure > 140/90 mmHg),
medication use (self-reported number of drugs used on
a regular basis) and disability (self-reported functional
status). Further, we constructed variables of frailty,
disability and multimorbidity similar to those in KORA-
Age. Frailty was defined by a slight modification of the
criteria by Fried et al. [20, 21], i.e. by grip strength (mea-
sured by Martins vigorimeter), gait speed (Timed Up
and Go (TUG) test), physical activity level (self-re-
ported), exhaustion (self-reported single item from the
Hospital Symptom Check List 10 (HSCL-10)). Partici-
pants were defined as frail if they met one or more
criteria and non-frail if no criteria was met. Only a
representative subsample of participants attending the
second visit had TUG and grip strength measured,
therefore frailty was scored for only a subsample (n =
595). Disability was defined by self-reported functional
status (difficulties with moving around in the home, get-
ting out of the home without assistance, participate in
leisure activities, using public transport, daily shopping),
and participants were defined as disabled if they an-
swered yes on one or more of the disability questions.
Only participants 70 years and older were given the
questionnaire questions on disability, therefore disability
could only be scored in a subsample (n = 1284). Multi-
morbidity was defined by a modified version of the
Charlson Comorbidity Index (CCI) [22, 23] without
weighting (self-reported; yes if ≥3 of the following dis-
eases: asthma/emphysema/chronic bronchitis, cancer
(ever), diabetes, stroke, heart attack/angina pectoris,
peptic ulcer)). A detailed overview of all variables for the
present study is shown in an additional file (see Add-
itional file 1), including definitions of concepts and co-
herence with the KORA-Age study.
Statistics
We used means with standard deviations (SD) for con-
tinuous variables, and percentages for categorical vari-
ables to present descriptive characteristics of the total
sample and age groups (Table 1), sex and age groups
(Table 2) and fall status (Table 3), as well as for compari-
son with the KORA-Age sample (Additional file 2).
Two-way t-tests for comparisons of means and Chi-
square tests for categorical variables were used to com-
pare groups (sex, age, and fall status) (Tables 1, 2 and 3),
as well as between Tromsø 5 and KORA-Age (Add-
itional file 2). Further, we used logistic regression models
to assess the association between hemoglobin values (as
a continuous variable; per SD decrease) or anemia (di-
chotomous; anemic or non-anemic) and falls (Table 4).
Four different models were used; Model 1: unadjusted;




65-74 years ≥ 75 years
(N = 2441) (N = 1637) (N = 804)
Mean age, years 72.0 (4.8) 69.2 (2.9) 77.6 (2.2) –
Fallsa, n (%) 33 (803/2441) 32 (518/1637) 36 (285/804) 0.060
Anemiab, n (%) 8 (188/2441) 6 (95/1687) 12 (93/804) < 0.0001
Hemoglobin, g/dl 13.9 (1.1) 13.9 (1.1) 13.7 (1.2) < 0.0001
Multimorbidityc, n (%) 4 (74/1825) 3 (36/1288) 7 (38/537) < 0.0001
Disabilityd, n (%) 26 (339/1284) 20 (124/635) 33 (215/649) < 0.0001
Frailtye, n (%) 39 (232/592) 25 (16/65) 41 (216/527) 0.011
Hypertensionf (%) 65 (1592/2440) 62 (1006/1637) 73 (586/803) < 0.0001
Use of antihypertensives, n (%) 31 (741/2363) 29 (467/1588) 35 (274/775) 0.003
Use of ≥ 5 drugsg, n (%) 16 (293/1841) 15 (180/1196) 18 (113/645) 0.167
Low physical activity, n (%) 8 (180/2147) 7 (98/1471) 12 (82/676) < 0.0001
Body mass index, kg/m2 26.7 (4.1) 26.7 (4.1) 26.6 (4.2) 0.567
1P-value for age difference (two-sided t-test for comparisons of means for continuous variables and Chi-square test for categorical variables)
aSelf-reported fall last year
bWHO criteria (< 12 g/dl in women, < 13 g/dl in men)
cSelf-reported ≥ 3 of the following diseases: asthma/emphysema/chronic bronchitis, cancer (ever), diabetes, stroke, coronary heart disease, peptic ulcer
dSelf-reported functional status
eModified Fried’s criteria
fBlood pressure > 140/90 mmHg
gSelf-reported drugs used on a regular basis
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Model 2: adjusted for age and sex; Model 3: adjusted for
age, sex and medication use; and Model 4: adjusted for
age, sex, medication use and disability. To examine the
joint effect of anemia and frailty or disability on the oc-
currence of falls, in a further step, a model combining
anemia and frailty, and anemia and disability, was cre-
ated (Table 5). The participants were classified into four
categories: 1) anemic and disabled/frail, 2) anemic and
not disabled/frail, 3) not anemic and disabled/frail, and
4) not anemic and not disabled/frail (reference category),
in three different models; Model 1: unadjusted, Model 2:
adjusted for age and sex, Model 3: adjusted for age, sex
and medication use. The results from the logistic re-
gression analyses are presented as odds ratios (ORs)
with corresponding 95% confidence intervals (CIs) (Ta-
bles 4 and 5). The analyzes were performed in the total
sample, in addition to sex- and age-stratified (age-group
65-74 years and 75+ years, in accordance with the
KORA-Age Study) analyses, when applicable. No age-
or sex-stratification was used for the joint analysis of
anemia and frailty/disability due to low subsample sizes.
P-values < 0.05 were considered statistically significant.
All analyses were performed using SPSS 23.0 (IBM




Tables 1 and 2 show the study characteristics in the
Tromsø 5 study sample in the total sample and by sex
and age. Mean hemoglobin was within normal range;
13.4 g/dL (SD 1.0) in women and 14.4 g/dL (SD 1.9) in
men. The prevalence of anemia was 6% in women and
9% in men. The older women had higher mean
hemoglobin and lower prevalence of anemia (8%) com-
pared to the older men (16%) (p = 0.001). A total of 33%
reported to have fallen last year, with no statistically sig-
nificant sex or age differences. The overall prevalence of
multimorbidity, disability and frailty was 4%, 26% and
39%, respectively. Overall, the older age group had lower
mean hemoglobin levels and higher prevalence of
anemia, multimorbidity, disability and frailty compared
to the younger age group. Overall, the women in both
age groups had higher prevalence of disability compared
to men, and older women had higher prevalence of
frailty compared to older men.
Table 2 Study sample characteristics by sex and age, mean (SD) or percentages (number of total number measured (n/N)). The
Tromsø Study 2001-2002
Women Men p-value1
Variable All Age-group Age-group All Age-group Age-group All Age-group Age-group
65-74 years ≥ 75 years 65-74 years ≥ 75 years 65-74 years ≥ 75 years
(N = 1321) (N = 863) (N = 458) (N = 1120) (N = 774) (N = 346)
Mean age, years 72.3 (4.8) 69.4 (2.9) 77.7 (2.2) 71.8 (4.8) 69.1 (2.9) 77.8 (2.2) 0.013 0.076 0.880
Fallsa, n (%) 33 (442/1321) 32 (276/863) 36 (166/458) 32 (361/1120) 31 (242/774) 34 (119/346) 0.520 0.756 0.587
Anemiab, n (%) 6 (85/1312) 6 (47/863) 8 (38/458) 9 (103/1120) 6 (48/774) 16 (55/346) 0.011 0.514 0.001
Hemoglobin, g/dl 13.4 (1.0) 13.5 (0.9) 13.4 (1.0) 14.5 (1.1) 14.5 (1.1) 14.1 (1.2) – – –
Multimorbidityc,
n (%)
4 (34/932) 3 (18/659) 6 (16/273) 4 (40/893) 3 (18/629) 8 (22/264) 0.368 0.887 0.264
Disabilityd, n (%) 31 (220/701) 26 (85/334) 37 (135/367) 20 (119/583) 13 (39/301) 28 (80/282) < 0.001 < 0.0001 0.024
Frailtye, n (%) 47 (141/302) 33 (10/30) 48 (131/272) 31 (91/290) 17 (6/35) 33 (85/255) < 0.001 0.131 0.001
Hypertensionf (%) 68 (892/1321) 64 (552/863) 74 (340/458) 63 (700/1119) 59 (454/774) 71 (246/345) 0.010 0.028 0.354
Use of antihypertensives,
n (%)
31 (339/1277) 29 (246/839) 35 (153/438) 31 (342/1086) 30 (221/749) 36 (121/337) 0.898 0.935 0.779
Use of ≥ 5 drugsg, n (%) 15 (157/1044) 14 (95/663) 16 (62/381) 17 (136/797) 16 (85/533) 19 (51/264) 0.239 0.436 0.317
Low physical activity, n (%) 11 (116/1103) 8 (61/742) 15 (55/361) 6 (64/1044) 5 (37/729) 9 (27/315) < 0.001 0.016 0.008
Body mass index,
kg/m2
27.0 (4.5) 26.9 (4.6) 27.0 (4.4) 26.4 (3.5) 26.5 (3.5) 26.1 (3.7) < 0.001 0.048 0.001
1P-value for sex difference (two-sided t-test for comparisons of means for continuous variables and Chi-square test for categorical variables)
aSelf-reported fall last year
bWHO criteria (< 12 g/dl in women, < 13 g/dl in men)
cSelf-reported ≥ 2 of the following diseases: asthma/emphysema/chronic bronchitis, cancer (ever), diabetes, stroke, coronary heart disease, peptic ulcer
dSelf-reported functional status
eModified Fried’s criteria
fBlood pressure > 140/90 mmHg
gSelf-reported drugs used on a regular basis
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Table 3 Fall and non-fall participant characteristics (percentages or means (SD)). The Tromsø Study 2001-2002














Mean age, years 72.2 (4.9) 72.3 (4.9) 72.1 (4.9) 72.0 (4.8) 72.2 (4.8) 71.6 (4.8) 0.219 0.706 0.172
Mean hemoglobin, g/dl 13.8 (1.1) 13.4 (0.9) 14.4 (1.1) 13.9 (1.1) 13.4 (1.0) 14.4 (1.1) 0.550 0.373 0.739
Anemiaa, % 7.9 7.0 8.9 7.6 6.1 9.4 0.852 0.543 0.791
Mulitimorbidityb, % 4.2 4.6 3.4 4.0 3.2 4.8 0.849 0.332 0.530
Disabilityc, % 28.0 32.0 23.2 25.6 31.0 19.0 0.361 0.795 0.239
Frailtyd, % 41.3 43.6 38.5 38.1 48.4 27.8 0.450 0.421 0.064
Hypertensione, % 63.3 64.7 61.5 66.2 68.9 63.0 0.150 0.121 0.613
Use of antihypertensives, % 33.2 33.7 32.5 30.5 30.0 31.0 0.187 1.277 0.633
Use of ≥ 5 drugsf, % 18.1 16.1 20.6 14.9 14.5 15.3 0.077 0.483 0.063
Low physical activity level, % 6.5 8.4 4.5 9.3 11.6 6.9 0.029 0.096 0.126
Body mass index, kg/m2 26.8 (4.2) 27.2 (4.6) 26.3 (3.5) 26.7 (4.1) 26.9 (4.5) 26.4 (3.5) 0.471 0.213 0.574
1P-value for difference between fall and non-fall participants (two-sided t-test for comparisons of means for continuous variables and Chi-square test for
categorical variables)
aWHO criteria (< 12 g/dl in women, < 13 g/dl in men)
bSelf-reported ≥ 2 of the following diseases: asthma/emphysema/chronic bronchitis, cancer (ever), diabetes, stroke, coronary heart disease, peptic ulcer
cSelf-reported functional status
dModified Fried’s criteria
eBlood pressure > 140/90 mmHg
fSelf-reported drugs used on a regular basis
Table 4 Association between hemoglobin or anemia and fall, by sex and age, OR (CI). The Tromsø Study 2001-02
Unadjusted model Model 1b Model 2c Model 3d
Hemoglobin level (continuous, per SD decrease)
Total sample 1.03 (0.94-1.12) 1.01 (0.92-1.11) 1.03 (0.93-1.14) 0.94 (0.81-1.09)
Age 65-74 1.04 (0.93-1.15) 1.04 (0.92-1.17) 1.09 (0.95-1.25) 1.06 (0.85-1.32)
Age≥ 75 0.98 (0.85-1.14) 0.97 (0.83-1.13) 0.94 (0.80-1.11) 0.87 (0.71-1.05)
Women 1.06 (0.93-1.22) 1.06 (0.93-1.22) 1.02 (0.88-1.19) 0.85 (0.62-1.05)
Age 65-74 1.13 (0.94-1.35) 1.09 (0.89-1.34) 0.79 (0.55-1.11)
Age≥ 75 0.97 (0.79-1.20) 0.94 (0.75-1.18) 0.90 (0.69-1.17)
Men 0.98 (0.86-1.11) 0.97 (0.85-1.10) 1.03 (0.89-1.20) 1.06 (0.87-1.30)
Age 65-74 0.97 (0.82-1.14) 1.09 (0.90-1.31) 1.40 (1.03-1.91)
Age≥ 75 0.97 (0.78-1.20) 0.94 (0.74-1.21) 0.84 (0.63-1.11)
Anemiaa
Total sample 1.03 (0.75-1.41) 1.02 (0.74-1.40) 1.00 (0.70-1.44) 0.83 (0.50-1.37)
Age 65-74 1.05 (0.67-1.63) 1.05 (0.68-1.63) 1.06 (0.64-1.77) 1.15 (0.52-2.55)
Age≥ 75 0.95 (0.60-1.50) 0.96 (0.61-1.52) 0.92 (0.55-1.56) 0.69 (0.36-1.32)
Women 1.15 (0.73-1.82) 1.15 (0.73-1.82) 1.05 (0.62-1.77) 0.55 (0.23-1.29)
Age 65-74 1.10 (0.59-2.05) 0.96 (0.46-2.00) 0.44 (0.09-2.03)
Age≥ 75 1.16 (0.59-2.29) 1.11 (0.52-2.36) 0.64 (0.22-1.84)
Men 0.94 (0.61-1.46) 0.90 (0.58-1.40) 0.95 (0.57-1.58) 1.08 (0.57-2.03)
Age 65-74 1.00 (0.53-1.88) 1.17 (0.57-2.38) 2.17 (0.76-6.22)
Age≥ 75 0.83 (0.45-1.54) 0.78 (0.38-1.62) 0.72 (0.32-1.65)
OR Odds Ratios, CI Confidence Intervals
aWHO criteria (<12 g/dl in women, <13 g/dl in men)
bModel 1: Adjusted for age (years, only for the total sample and in sex-stratified analyses) and sex (only in the total sample and in the age-stratified analyses)
cModel 2: In addition to Model 1 adjusted for number of drugs (self-reported)
dModel 3: In addition to Model 2 adjusted for disability (self-reported)
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Comparison of the samples from Tromsø 5 and KORA-Age
Comparison between characteristics of the Tromsø 5
Study sample and the KORA-Age Study (Additional file
2) show that mean hemoglobin levels and prevalence of
fall was higher in the Tromsø Study, while mean age and
body mass index, and prevalence of anemia, multimor-
bidity, hypertension, polypharmacy and use of antihyper-
tensives was lower, compared to the KORA-Age Study.
There was no difference in prevalence of disability and
frailty between the two studies.
Fall and non-fall-participant characteristics
Table 3 show the characteristics of participants who
reported falling, compared to participants who reported
no fall the last year. There were no statistically signifi-
cant differences in the characteristics among those who
reported falling and those who reported no fall, neither
in the total sample or when stratified by sex. The excep-
tion was that in the total sample, participants who
reported falling had statistically significant higher
prevalence of low physical activity level, but not in the
sex-stratified groups.
Association between anemia or hemoglobin and falls
We found no statistically significant associations
between anemia or hemoglobin and falls in the logistic
regression models (Table 4), neither in the crude
analysis, nor when adjusted for sex and/or age (when
applicable), drug use and disability (fully adjusted
models; OR, 95% CI: 0.83, 0.50-1.37 and 0.94, 0.81-1.09,
respectively). The sole exception was a statistically
significant association between hemoglobin levels and
falls, in the fully adjusted model, in the subsample of
men aged 65-74 years (OR, 95% CI per SD decrease
1.40, 1.03-1.91).
Association between anemia, frailty or disability and falls
We found no statistically significant association between
combinations of anemia and frailty, or anemia and dis-
ability, and falls (OR 95% CI: 0.94, 0.40-2.22 and 0.73,
0.32-1.67, respectively) (Table 5).
Discussion
In this replication analysis from the Tromsø Study, in
accordance with the main findings from the original
study by Thaler-Kall et al. from the KORA-Age Study,
we found no statistically significant association between
measured anemia or hemoglobin and self-reported falls
among women and men aged 65 years and older.
Comparison of the variables and samples from Tromsø 5
and KORA-Age
Considerable efforts were made to reconstruct the co-
variate variables from KORA-Age with the available data
from the Tromsø Study. However, this was not possible
for all concepts.
Both prevalence of anemia and falls were higher in the
KORA-Age sample than in the Tromsø Study sample.
The prevalence of anemia in men and women was con-
sistent between the current Tromsø 5 Study and a previ-
ous analysis from the Tromsø 4 Study (1994-95) [24].
The observed differences in prevalence of anemia,
morbidity and medication use between the two samples
were likely to be due to the fact that the Tromsø Study
participants were on average 4 years younger than the
KORA-Age participants. This is not considered to have
influenced the differences in main results, as all analyses
were performed in either strata of age groups or adjusted
for age, in both studies. The prevalence of the covariates
for the joint analysis, disability and frailty, did not differ
between the studies.
Table 5 Associations between anemiaa and frailtyb or disabilityc, and fallsd, total sample (n), OR (CI). The Tromsø Study 2001-2002
Unadjusted model Model 1e Model 2f
Anemic & frail (30) 1.03 (0.48-2.22) 0.98 (0.45-2.13) 0.94 (0.40-2.22)
Anemic, not frail (36) 0.80 (0.38-1.66) 0.77 (0.36-1.61) 0.74 (0.32-1.85)
Not anemic & frail (202) 1.22 (0.91-1.65) 1.15 (0.84-1.59) 1.23 (0.87-1.74)
Not anemic & not frail (2173) 1 (ref) 1 (ref) 1 (ref)
Anemic & disabeled (34) 0.75 (0.35-1.63) 0.74 (0.34-1.60) 0.78 (0.34-1.81)
Anemic, not disabeled (71) 1.00 (0.60-1.68) 0.97 (0.57-1.63) 0.92 (0.50-1.70)
Not anemic & disabeled (305) 1.18 (0.90-1.55) 1.15 (0.87-1.52) 1.14 (0.83-1.56)
Not anemic & not disabeled (874) 1.00 (ref) 1.00 (ref) 1.00 (ref)
OR Odds Ratios from logistic regression models, CI Confidence Intervals
aWHO criteria (< 12 g/dl in women, < 13 g/dl in men)
bModified Fried’s criteria
cSelf-reported abilities to perform daily activities
dSelf-reported fall last year
eModel 1: Adjusted for age (years) and sex
fModel 2: In addition to Model 1 adjusted number of drugs (self-reported)
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Fall and non-fall participant characteristics
We did not find differences in characteristics between
those who reported falling and those who reported no
fall the last year. In Thaler-Kall’s analysis, participants
who reported falling last year were older, and had higher
prevalence of frailty and disability. Previous studies have
reported associations between risk of falls and age [15],
frailty [25] and disability [26]. This could not be
supported by the current study.
Association between anemia or hemoglobin and falls
In accordance to the findings from Thaler-Kall et al.
[17], we found no independent statistically significant
association between hemoglobin or anemia and falls.
The exception was an observed association between
hemoglobin and falls among men aged 65–74 years,
considered a coincidental finding in this subsample, that
could not be supported by the analysis of anemia and
falls, when adjusted for the same covariates.
Several previous studies including both prospective
[11], case-control [14, 27] and retrospective [8, 15, 16]
analyses report a positive association between anemia
and falls. However, some of these studies investigated
only injurious falls as the outcome [16, 27], self-reported
anemia as the predictor [27], included selected popula-
tions such as hospitalized patients [14] or nursing home
residents [8], and/or included smaller study samples [8,
11, 14, 15] than the current study.
Association between anemia, frailty or disability and falls
We found neither a statistical significant association be-
tween combinations of anemia & frailty and falls, nor
with combinations of anemia & disability and falls. In
the KORA-Age Study [17], a joint effect of anemia &
disability and falls was found. Participants who were dis-
abled, with or without anemia, had a higher risk of fall
compared to those who were not disabled, with or with-
out anemia. This finding was not supported in the
current analysis. In both samples, 25% participants were
defined as disabled and 40% as frail. Disability was
defined slightly different in the two samples; in the
Tromsø Study using a non-validated questionnaire, in
KORA-Age by a validated scoring tool for activities of
daily living. The definition of frailty was close to identi-
cal between the two studies, and no joint effect of
anemia & frailty was found in either of the studies.
Frailty, disability and comorbidity are distinct clinical
entities, however the concepts are often related, and dif-
ficult to disentangle [28]. Previous studies have found
anemia related to disability [12] and physical function
[3]. A recent review study [29] found a U-shaped associ-
ation between physical activity and falls, where the most
inactive and the most active have the highest risk of fall-
ing. This can be due to different fall contexts, i.e. an
outdoor fall as consequence of for example engaging in
sport activities (associated with good health and an
active lifestyle) or an indoor fall as a consequence of dif-
ferent impairments (associated with disability, frailty
and/or comorbidity). A previous analysis from the
Tromsø 4 Study [30] of participants aged 55-75 years,
found that men with anemia had a two-fold risk for inci-
dent non-vertebral fractures compared to men without
anemia, but no association was found between anemia
and fractures among women. Risk factors for indoor and
outdoor falls differ [31], therefore the context and location
of the fall may be a confounder in analyses of predictors
of falls in the elderly. Due to limitation of available data,
this could not be investigated in the current study.
Strengths and limitations
A strength of the current analysis is that the design of
the Tromsø Study is largely comparable to the KORA-
Age Study, consists of a larger study sample, and is
therefore suitable for replication purposes. However, the
main limitation is that not all covariates used in the
KORA-Age analysis were available in the Tromsø Study.
Due to differences in available variables and data collec-
tion tools, some of the definitions of covariates used in
the analysis were not identical between the two studies,
which could have led to misclassification bias. Neverthe-
less, the study designs and variable definitions have been
presented in detail, to facilitate comparison and inter-
pretation of results. A general limitation yielding both
the current analysis and the KORA-Age analysis is the
cross-sectional design that cannot discern possible
causal relationships between predictors and outcome. In
both studies, there is a gap in time between the mea-
sured hemoglobin level and the reported event of falling
(up to 1 year), so that the anemia status could have been
different at the time of falling. In both studies, the
phrasing of the fall question could not distinguish be-
tween falls in different contexts, for example whether
the fall occurred indoors or outdoors. Further, in The
Tromsø Study, the prevalence of anemia in women was
two-three times higher when using the WHO criteria
compared to the 2.5 percentile [24]. By defining anemia
according to the WHO criteria, some non-anemic
women were classified as anemic and this could have
affected the results in this study. In addition to this, in
both The Tromsø Study and the KORA-Age study there
is a risk of selection bias, i.e. yielding exclusion of partic-
ipants who were not able to attend the examinations
due to their health status, which could possibly lead to
an underestimation of the association between anemia
and falls. Nevertheless, the main results of the two stud-
ies are coherent, and the high participation rate in the
Tromsø Study is a strength for external validity.
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Conclusions
In this replication analysis from the Tromsø Study, in
accordance with the results from the KORA-Age study,
no statistically significant association between anemia or
hemoglobin and falls was found among community-
living women and men aged 65 years or older. Further
studies using a prospective design to investigate anemia
as a predictor for unintentional falls are needed.
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